Due to a limited supply, we are unable to accept phone calls to schedule COVID-19 vaccinations.
For the most up-to-date information, please check our COVID-19 Vaccination Website.
Research by family linkage studies identified a possible skin cancer gene. This gene, called p16, also known as CDKN2A, INK4A or MTS1, accounts for up to 40 percent of these hereditary skin cancer cases.
Recently there have been updated recommendations regarding testing for this gene. If you have had multiple skin cancers, or family members with skin cancer or pancreatic cancer, genetic testing could be right for you and your family.